Skip to main content
Clinical Trials/ISRCTN37161699
ISRCTN37161699
Completed
未知

A randomised controlled trial of adjunctive plasma exchange in patients with newly diagnosed multiple myeloma and acute renal failure

Imperial College London (UK)0 sites280 target enrollmentSeptember 21, 2000

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Imperial College London (UK)
Enrollment
280
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2000
End Date
December 31, 2008
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Imperial College London (UK)

Eligibility Criteria

Inclusion Criteria

  • Patients with newly diagnosed myeloma and acute renal failure, aged 18 years or over
  • Added as of 10/12/2009:
  • 1\. Newly diagnosed myeloma
  • 2\. Acute renal failure (creatinine greater than 500 mmol/l, urine output less than 400 ml/d or requiring dialysis)
  • 3\. Aged 18 years or over, either sex
  • 4\. Written informed consent
  • 5\. No previous chemotherapy for myeloma
  • 6\. No significant intrinsic renal disease unrelated to myeloma

Exclusion Criteria

  • Does not comply with above inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials